相关实验视频
Updated: Aug 2, 2026
08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
10.4K
在小鼠中,Engeletin通过AMPK通路减轻了多克索鲁比诱导的心脏毒性
Xin Chen1,2,3, Xing Zhong4, Dan Luo1,2,3
1Cardiovascular Disease Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
Frontiers in pharmacology
|March 16, 2026
概括
英格列 (ENG) 通过激活AMPK通路来保护免受多克索鲁比诱导的心脏毒性 (DIC). 这种天然产品可以改善心脏功能障碍和细胞损伤,为DIC提供了潜在的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- doxorubicin (DOX) 是一种重要的抗癌药物,但其临床使用受到严重心脏毒性的限制.
- doxorubicin 诱导的心脏毒性 (DIC) 缺乏有效的保护剂.
- 英格列 (ENG),是一种天然产品,表现出多种生物活性和潜在的治疗益处.
研究的目的:
- 调查Engeletin (ENG) 对多克索鲁比诱导的心脏毒性 (DIC) 的保护作用.
- 阐明NG在DIC中的心脏保护作用的基础分子机制.
主要方法:
- 建立了体外 (H9C2心肌细胞) 和体内 (C57BL/6小鼠) 的DIC.模型.
- 评估心脏功能和结构,使用心声回声学,组织学和电子显微镜.
- 利用分子生物学技术 (西式涂抹,qPCR,ELISA,流细胞计) 来评估亡,自,氧化应激,炎症和线粒体损伤. 使用抑制剂研究了AMPK通路的作用.
主要成果:
- 多克索鲁比治疗导致心脏功能受损,诱导纤维化,亡,氧化应激,炎症,自失调和线粒体损伤.
- ENG治疗显著改善了这些DOX诱导的有害影响,特别是减少心肌亡,自和氧化应激.
- ENG的保护作用是通过AMPK通路的激活来实现的,正如使用AMPK抑制剂的实验证实的那样.
结论:
- 英格列丁 (ENG) 显示出显著的心脏保护作用,防止多克索鲁比诱导的心脏毒性 (DIC).
- ENG通过激活AMPK通路来发挥其保护作用.
- ENG是预防和治疗DIC的有前途的治疗候选药物.
相关概念视频
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...